Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

August’s top stories: Pfizer’s cancer trial, Jardiance diabetes study results

Pfizer, Alliance Foundation Trials (AFT) and Austrian Breast & Colorectal Cancer Study Group (ABCSG) have launched Ibrance’s trial for receptor-positive early breast cancer, AstraZeneca and Peregrine partner for combination clinical trial in solid tumours and Boehringer and Eli Lilly present Jardiance study results for type 2 diabetes. Drugdevelopment-technology.com wraps up key headlines from August.

Go Top